[Angiosarcoma of the head and neck treated with bevacizumab and paclitaxel]

Ann Dermatol Venereol. 2018 Jun-Jul;145(6-7):451-453. doi: 10.1016/j.annder.2018.02.008. Epub 2018 Apr 24.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Immunological / administration & dosage*
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Bevacizumab / administration & dosage*
  • Drug Therapy, Combination
  • Fatal Outcome
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Hemangiosarcoma / drug therapy*
  • Humans
  • Male
  • Paclitaxel / administration & dosage*
  • Skin Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents, Immunological
  • Antineoplastic Agents, Phytogenic
  • Bevacizumab
  • Paclitaxel